SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: Harry Ehrlich who wrote (1072)1/30/1998 9:42:00 PM
From: arnie h  Read Replies (2) | Respond to of 2173
 
Thanks for the chart read. A point to keep in mind has to do with the way capital gains currently works. The low rate for an 18 month hold would seem to be just about the right timing for Amylin. It should be go or no-go by then. Now seems like a pretty good time to buy if you are convinced testing will go well.




To: Harry Ehrlich who wrote (1072)1/31/1998 4:02:00 PM
From: D.Right  Read Replies (1) | Respond to of 2173
 
Dear Harry:

Thanks for the TA update. Keep the thread informed if you can in the future.

Have a good weekend.

D.Right


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News